SLC20A1

From WikiMD's WELLNESSPEDIA


SLC20A1
Symbol SLC20A1
HGNC ID 10915
Alternative symbols
Entrez Gene 6574
OMIM 158378
RefSeq NM_005415
UniProt Q8WUM9
Chromosome 2q14
Locus supplementary data


SLC20A1 is a gene that encodes a protein known as the sodium-dependent phosphate transporter 1 (PiT-1). This protein is involved in the transport of phosphate ions across cell membranes, which is crucial for various cellular functions including metabolism, signal transduction, and nucleic acid synthesis.

Function[edit]

The SLC20A1 gene product, PiT-1, is a type III sodium-dependent phosphate transporter. It plays a significant role in maintaining phosphate homeostasis in the body. Phosphate is essential for bone mineralization, energy storage and release, and the regulation of acid-base balance in the body.

Clinical Significance[edit]

Mutations or dysregulation of the SLC20A1 gene can lead to disorders related to phosphate metabolism. Abnormal phosphate levels can result in conditions such as hyperphosphatemia or hypophosphatemia, which can affect bone health and lead to osteoporosis or rickets.

Expression[edit]

SLC20A1 is expressed in a wide range of tissues, indicating its fundamental role in cellular physiology. It is particularly important in tissues with high phosphate turnover, such as the kidney, intestine, and bone.

Interactions[edit]

The PiT-1 protein interacts with various other proteins and molecules to facilitate phosphate transport. It is regulated by factors such as parathyroid hormone and fibroblast growth factor 23 (FGF23), which are involved in phosphate homeostasis.

Research[edit]

Ongoing research is focused on understanding the precise mechanisms by which SLC20A1 regulates phosphate transport and its implications in disease states. Studies are also exploring potential therapeutic targets for conditions resulting from phosphate imbalance.

See Also[edit]

References[edit]


External Links[edit]

Template:Transporter proteins



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.